These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10172003)

  • 1. Regulation: threat or opportunity?
    Sparks S
    Med Device Technol; 1993 Nov; 4(9):34-7. PubMed ID: 10172003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not long to go: the end of the transition period approaches.
    Cutler IR
    Med Device Technol; 1997 Nov; 8(9):28-30. PubMed ID: 10174627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical device regulation in the European Union.
    Horton LR
    Food Drug Law J; 1995; 50(3):461-76. PubMed ID: 10343013
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increased safety requirements concerning products of medical technology. New rules make CE labeling compulsory in most cases].
    Liedström G
    Lakartidningen; 1998 Aug; 95(35):3681-2. PubMed ID: 9748783
    [No Abstract]   [Full Text] [Related]  

  • 5. European legislation of biomedical technology.
    Mambretti C
    Ann Ist Super Sanita; 1995; 31(1):109-12. PubMed ID: 8546358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European medical device regulation: a new era?
    Donawa M
    Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts on industry of Europe's emerging chemicals policy REACh.
    Angerer G; Nordbeck R; Sartorius C
    J Environ Manage; 2008 Mar; 86(4):636-47. PubMed ID: 17321032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complying with US and European change control requirements, Part II.
    Donawa ME
    Med Device Technol; 1997 Nov; 8(9):13-6. PubMed ID: 10174625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovation and patents: in vitro diagnostics.
    Carter S
    Med Device Technol; 2003 May; 14(4):24. PubMed ID: 12774574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What impact will EPPO's new resistance risk assessment guideline have on selection pressure in the European Union?
    Leonard PK; Dutton R
    Pest Manag Sci; 2002 Sep; 58(9):939-43. PubMed ID: 12233185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarity and risk: the challenges of the new technologies.
    Williams D
    Med Device Technol; 2001 Nov; 12(9):12-4. PubMed ID: 12938531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. User reporting of medical device related incidents.
    Sievänen H
    Med Device Technol; 2003 May; 14(4):26-9. PubMed ID: 12774575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clean room technologies of the 1990s.
    Möller AL
    Med Device Technol; 1992 Oct; 3(7):24-33. PubMed ID: 10147983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual recognition of pharmaceutical good manufacturing practice inspection reports, medical device quality system audit reports, and certain medical device product evaluation reports between the United States and the European Community--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(215):60122-64. PubMed ID: 10187390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empowering patients: total product life cycle for medical devices.
    Ciarkowski AA
    Stud Health Technol Inform; 2003; 92():85-93. PubMed ID: 15455843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Draft EU regulation on paediatric medicines: some improvements but still far from perfect.
    Prescrire Int; 2006 Feb; 15(81):32-3. PubMed ID: 16548115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Great regulatory expectations.
    Donawa M
    Med Device Technol; 1999 Dec; 10(10):24-7. PubMed ID: 10788264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern regulatory impact analysis: the experience of the European Union.
    Ballantine B; Devonald B
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):57-68. PubMed ID: 16307835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M; Nordström K
    Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
    Mackler BF; Barach M
    J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.